DANAHER CORP (DHR) Stock Fundamental Analysis

NYSE:DHR • US2358511028

210.64 USD
+1.28 (+0.61%)
At close: Feb 27, 2026
210.64 USD
0 (0%)
After Hours: 2/27/2026, 8:04:00 PM
Fundamental Rating

6

Taking everything into account, DHR scores 6 out of 10 in our fundamental rating. DHR was compared to 57 industry peers in the Life Sciences Tools & Services industry. DHR has an excellent profitability rating, but there are some minor concerns on its financial health. DHR is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • DHR had positive earnings in the past year.
  • DHR had a positive operating cash flow in the past year.
  • In the past 5 years DHR has always been profitable.
  • In the past 5 years DHR always reported a positive cash flow from operatings.
DHR Yearly Net Income VS EBIT VS OCF VS FCFDHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 4.33%, DHR is in the better half of the industry, outperforming 78.95% of the companies in the same industry.
  • The Return On Equity of DHR (6.88%) is better than 78.95% of its industry peers.
  • The Return On Invested Capital of DHR (5.19%) is better than 75.44% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for DHR is significantly below the industry average of 11.57%.
Industry RankSector Rank
ROA 4.33%
ROE 6.88%
ROIC 5.19%
ROA(3y)4.99%
ROA(5y)6.19%
ROE(3y)7.87%
ROE(5y)10.34%
ROIC(3y)5.75%
ROIC(5y)6.56%
DHR Yearly ROA, ROE, ROICDHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10

1.3 Margins

  • The Profit Margin of DHR (14.71%) is better than 84.21% of its industry peers.
  • In the last couple of years the Profit Margin of DHR has remained more or less at the same level.
  • DHR's Operating Margin of 19.15% is amongst the best of the industry. DHR outperforms 84.21% of its industry peers.
  • In the last couple of years the Operating Margin of DHR has remained more or less at the same level.
  • With a decent Gross Margin value of 59.17%, DHR is doing good in the industry, outperforming 77.19% of the companies in the same industry.
  • In the last couple of years the Gross Margin of DHR has remained more or less at the same level.
Industry RankSector Rank
OM 19.15%
PM (TTM) 14.71%
GM 59.17%
OM growth 3Y-12.28%
OM growth 5Y0.11%
PM growth 3Y-17.98%
PM growth 5Y-1.36%
GM growth 3Y-0.91%
GM growth 5Y1.09%
DHR Yearly Profit, Operating, Gross MarginsDHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

6

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DHR is destroying value.
  • DHR has less shares outstanding than it did 1 year ago.
  • DHR has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for DHR is higher compared to a year ago.
DHR Yearly Shares OutstandingDHR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
DHR Yearly Total Debt VS Total AssetsDHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

2.2 Solvency

  • DHR has an Altman-Z score of 4.24. This indicates that DHR is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of DHR (4.24) is better than 82.46% of its industry peers.
  • DHR has a debt to FCF ratio of 3.50. This is a good value and a sign of high solvency as DHR would need 3.50 years to pay back of all of its debts.
  • DHR has a better Debt to FCF ratio (3.50) than 82.46% of its industry peers.
  • A Debt/Equity ratio of 0.35 indicates that DHR is not too dependend on debt financing.
  • DHR has a Debt to Equity ratio of 0.35. This is comparable to the rest of the industry: DHR outperforms 47.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 3.5
Altman-Z 4.24
ROIC/WACC0.49
WACC10.64%
DHR Yearly LT Debt VS Equity VS FCFDHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.3 Liquidity

  • DHR has a Current Ratio of 1.87. This is a normal value and indicates that DHR is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.87, DHR is doing worse than 66.67% of the companies in the same industry.
  • DHR has a Quick Ratio of 1.51. This is a normal value and indicates that DHR is financially healthy and should not expect problems in meeting its short term obligations.
  • DHR has a worse Quick ratio (1.51) than 64.91% of its industry peers.
Industry RankSector Rank
Current Ratio 1.87
Quick Ratio 1.51
DHR Yearly Current Assets VS Current LiabilitesDHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

5

3. Growth

3.1 Past

  • DHR shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.14%.
  • The Earnings Per Share has been growing slightly by 4.40% on average over the past years.
  • Looking at the last year, DHR shows a small growth in Revenue. The Revenue has grown by 2.90% in the last year.
  • The Revenue has been growing slightly by 1.97% on average over the past years.
EPS 1Y (TTM)4.14%
EPS 3Y-10.69%
EPS 5Y4.4%
EPS Q2Q%4.21%
Revenue 1Y (TTM)2.9%
Revenue growth 3Y-2.67%
Revenue growth 5Y1.97%
Sales Q2Q%4.59%

3.2 Future

  • The Earnings Per Share is expected to grow by 9.81% on average over the next years. This is quite good.
  • Based on estimates for the next years, DHR will show a small growth in Revenue. The Revenue will grow by 5.43% on average per year.
EPS Next Y8.89%
EPS Next 2Y8.57%
EPS Next 3Y8.92%
EPS Next 5Y9.81%
Revenue Next Year4.37%
Revenue Next 2Y4.94%
Revenue Next 3Y5.47%
Revenue Next 5Y5.43%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
DHR Yearly Revenue VS EstimatesDHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B
DHR Yearly EPS VS EstimatesDHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

4

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 27.01, DHR can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Earnings ratio of DHR indicates a somewhat cheap valuation: DHR is cheaper than 71.93% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.07, DHR is valued at the same level.
  • With a Price/Forward Earnings ratio of 24.80, DHR is valued on the expensive side.
  • DHR's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. DHR is cheaper than 75.44% of the companies in the same industry.
  • DHR's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.05.
Industry RankSector Rank
PE 27.01
Fwd PE 24.8
DHR Price Earnings VS Forward Price EarningsDHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, DHR is valued a bit cheaper than the industry average as 63.16% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of DHR indicates a somewhat cheap valuation: DHR is cheaper than 73.68% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 28.31
EV/EBITDA 22.75
DHR Per share dataDHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates DHR does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of DHR may justify a higher PE ratio.
PEG (NY)3.04
PEG (5Y)6.14
EPS Next 2Y8.57%
EPS Next 3Y8.92%

6

5. Dividend

5.1 Amount

  • DHR has a yearly dividend return of 0.76%, which is pretty low.
  • Compared to an average industry Dividend Yield of 0.10, DHR pays a better dividend. On top of this DHR pays more dividend than 98.25% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, DHR's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.76%

5.2 History

  • The dividend of DHR is nicely growing with an annual growth rate of 7.08%!
  • DHR has been paying a dividend for at least 10 years, so it has a reliable track record.
  • As DHR did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)7.08%
Div Incr Years8
Div Non Decr Years8
DHR Yearly Dividends per shareDHR Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • DHR pays out 24.29% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of DHR is growing, but earnings are growing more, so the dividend growth is sustainable.
DP24.29%
EPS Next 2Y8.57%
EPS Next 3Y8.92%
DHR Yearly Income VS Free CF VS DividendDHR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B
DHR Dividend Payout.DHR Dividend Payout, showing the Payout Ratio.DHR Dividend Payout.PayoutRetained Earnings

DANAHER CORP

NYSE:DHR (2/27/2026, 8:04:00 PM)

After market: 210.64 0 (0%)

210.64

+1.28 (+0.61%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)01-28
Earnings (Next)04-20
Inst Owners82.98%
Inst Owner Change3.14%
Ins Owners10.82%
Ins Owner Change-19.03%
Market Cap148.90B
Revenue(TTM)24.57B
Net Income(TTM)3.61B
Analysts85.16
Price Target268.58 (27.51%)
Short Float %1.13%
Short Ratio1.9
Dividend
Industry RankSector Rank
Dividend Yield 0.76%
Yearly Dividend1.23
Dividend Growth(5Y)7.08%
DP24.29%
Div Incr Years8
Div Non Decr Years8
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.65%
Min EPS beat(2)2.56%
Max EPS beat(2)8.74%
EPS beat(4)4
Avg EPS beat(4)8.26%
Min EPS beat(4)2.56%
Max EPS beat(4)13.3%
EPS beat(8)7
Avg EPS beat(8)7.31%
EPS beat(12)11
Avg EPS beat(12)6.6%
EPS beat(16)15
Avg EPS beat(16)7.62%
Revenue beat(2)0
Avg Revenue beat(2)-0.38%
Min Revenue beat(2)-0.52%
Max Revenue beat(2)-0.23%
Revenue beat(4)2
Avg Revenue beat(4)0.41%
Min Revenue beat(4)-0.52%
Max Revenue beat(4)1.7%
Revenue beat(8)6
Avg Revenue beat(8)1.11%
Revenue beat(12)8
Avg Revenue beat(12)-0.11%
Revenue beat(16)11
Avg Revenue beat(16)-2.81%
PT rev (1m)0.95%
PT rev (3m)3.58%
EPS NQ rev (1m)-3.21%
EPS NQ rev (3m)-3.05%
EPS NY rev (1m)-0.09%
EPS NY rev (3m)-0.07%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)0.18%
Revenue NY rev (1m)0.31%
Revenue NY rev (3m)0.43%
Valuation
Industry RankSector Rank
PE 27.01
Fwd PE 24.8
P/S 6.06
P/FCF 28.31
P/OCF 23.21
P/B 2.83
P/tB N/A
EV/EBITDA 22.75
EPS(TTM)7.8
EY3.7%
EPS(NY)8.49
Fwd EY4.03%
FCF(TTM)7.44
FCFY3.53%
OCF(TTM)9.08
OCFY4.31%
SpS34.75
BVpS74.32
TBVpS-11.93
PEG (NY)3.04
PEG (5Y)6.14
Graham Number114.2
Profitability
Industry RankSector Rank
ROA 4.33%
ROE 6.88%
ROCE 6.14%
ROIC 5.19%
ROICexc 5.52%
ROICexgc 35.89%
OM 19.15%
PM (TTM) 14.71%
GM 59.17%
FCFM 21.41%
ROA(3y)4.99%
ROA(5y)6.19%
ROE(3y)7.87%
ROE(5y)10.34%
ROIC(3y)5.75%
ROIC(5y)6.56%
ROICexc(3y)6.08%
ROICexc(5y)6.96%
ROICexgc(3y)45.8%
ROICexgc(5y)53.12%
ROCE(3y)6.8%
ROCE(5y)7.77%
ROICexgc growth 3Y-17.71%
ROICexgc growth 5Y-9.63%
ROICexc growth 3Y-15.45%
ROICexc growth 5Y-0.71%
OM growth 3Y-12.28%
OM growth 5Y0.11%
PM growth 3Y-17.98%
PM growth 5Y-1.36%
GM growth 3Y-0.91%
GM growth 5Y1.09%
F-Score5
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 3.5
Debt/EBITDA 2.57
Cap/Depr 47.24%
Cap/Sales 4.71%
Interest Coverage 250
Cash Conversion 89.71%
Profit Quality 145.54%
Current Ratio 1.87
Quick Ratio 1.51
Altman-Z 4.24
F-Score5
WACC10.64%
ROIC/WACC0.49
Cap/Depr(3y)56.76%
Cap/Depr(5y)56.36%
Cap/Sales(3y)5.44%
Cap/Sales(5y)5.17%
Profit Quality(3y)134.42%
Profit Quality(5y)123.93%
High Growth Momentum
Growth
EPS 1Y (TTM)4.14%
EPS 3Y-10.69%
EPS 5Y4.4%
EPS Q2Q%4.21%
EPS Next Y8.89%
EPS Next 2Y8.57%
EPS Next 3Y8.92%
EPS Next 5Y9.81%
Revenue 1Y (TTM)2.9%
Revenue growth 3Y-2.67%
Revenue growth 5Y1.97%
Sales Q2Q%4.59%
Revenue Next Year4.37%
Revenue Next 2Y4.94%
Revenue Next 3Y5.47%
Revenue Next 5Y5.43%
EBIT growth 1Y-9.68%
EBIT growth 3Y-14.62%
EBIT growth 5Y2.08%
EBIT Next Year18.91%
EBIT Next 3Y11.44%
EBIT Next 5Y10.78%
FCF growth 1Y-0.68%
FCF growth 3Y-10.62%
FCF growth 5Y-0.59%
OCF growth 1Y-4.07%
OCF growth 3Y-9.02%
OCF growth 5Y0.66%

DANAHER CORP / DHR FAQ

What is the fundamental rating for DHR stock?

ChartMill assigns a fundamental rating of 6 / 10 to DHR.


What is the valuation status for DHR stock?

ChartMill assigns a valuation rating of 4 / 10 to DANAHER CORP (DHR). This can be considered as Fairly Valued.


What is the profitability of DHR stock?

DANAHER CORP (DHR) has a profitability rating of 7 / 10.


What is the expected EPS growth for DANAHER CORP (DHR) stock?

The Earnings per Share (EPS) of DANAHER CORP (DHR) is expected to grow by 8.89% in the next year.


Is the dividend of DANAHER CORP sustainable?

The dividend rating of DANAHER CORP (DHR) is 6 / 10 and the dividend payout ratio is 24.29%.